{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T10:01:51Z","timestamp":1781776911494,"version":"3.54.5"},"reference-count":112,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,11,14]],"date-time":"2017-11-14T00:00:00Z","timestamp":1510617600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,11,14]],"date-time":"2017-11-14T00:00:00Z","timestamp":1510617600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA166060"],"award-info":[{"award-number":["R01CA166060"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R00CA194198"],"award-info":[{"award-number":["R00CA194198"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1007\/s00223-017-0362-4","type":"journal-article","created":{"date-parts":[[2017,11,14]],"date-time":"2017-11-14T04:51:22Z","timestamp":1510635082000},"page":"141-151","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Hallmarks of Bone Metastasis"],"prefix":"10.1007","volume":"102","author":[{"given":"Rachelle W.","family":"Johnson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2892-9757","authenticated-orcid":false,"given":"Larry J.","family":"Suva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,11,14]]},"reference":[{"key":"362_CR1","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s11914-005-0003-0","volume":"3","author":"LJ Suva","year":"2005","unstructured":"Suva LJ, Gaddy D, Perrien DS, Thomas RL, Findlay DM (2005) Regulation of bone mass by mechanical loading: microarchitecture and genetics. Curr Osteoporos Rep 3:46\u201351","journal-title":"Curr Osteoporos Rep"},{"key":"362_CR2","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/nrrheum.2015.160","volume":"12","author":"MR Reagan","year":"2016","unstructured":"Reagan MR, Rosen CJ (2016) Navigating the bone marrow niche: translational insights and cancer-driven dysfunction. Nat Rev Rheumatol 12:154\u2013168","journal-title":"Nat Rev Rheumatol"},{"key":"362_CR3","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1172\/JCI28568","volume":"116","author":"T Yin","year":"2006","unstructured":"Yin T, Li L (2006) The stem cell niches in bone. J Clin Invest 116:1195\u20131201","journal-title":"J Clin Invest"},{"key":"362_CR4","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1056\/NEJMra030831","volume":"350","author":"GD Roodman","year":"2004","unstructured":"Roodman GD (2004) Mechanisms of bone metastasis. N Engl J Med 350:1655\u20131664","journal-title":"N Engl J Med"},{"key":"362_CR5","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/nrc3055","volume":"11","author":"KN Weilbaecher","year":"2011","unstructured":"Weilbaecher KN, Guise TA, McCauley LK (2011) Cancer to bone: a fatal attraction. Nat Rev Cancer 11:411\u2013425","journal-title":"Nat Rev Cancer"},{"key":"362_CR6","doi-asserted-by":"publisher","first-page":"248","DOI":"10.20892\/j.issn.2095-3941.2016.0023","volume":"13","author":"HS Zhou","year":"2016","unstructured":"Zhou HS, Carter BZ, Andreeff M (2016) Bone marrow niche-mediated survival of leukemia stem cells in acute myeloid leukemia: Yin and Yang. Cancer Biol Med 13:248\u2013259","journal-title":"Cancer Biol Med"},{"key":"362_CR7","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1038\/nm.3394","volume":"19","author":"DF Quail","year":"2013","unstructured":"Quail DF, Joyce JA (2013) Microenvironmental regulation of tumor progression and metastasis. Nat Med 19:1423\u20131437","journal-title":"Nat Med"},{"key":"362_CR8","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/nrendo.2015.185","volume":"12","author":"I Makhoul","year":"2016","unstructured":"Makhoul I, Montgomery CO, Gaddy D, Suva LJ (2016) The best of both worlds\u2014managing the cancer, saving the bone. Nat Rev Endocrinol 12:29\u201342","journal-title":"Nat Rev Endocrinol"},{"key":"362_CR9","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nrc1098","volume":"3","author":"IJ Fidler","year":"2003","unstructured":"Fidler IJ (2003) The pathogenesis of cancer metastasis: the \u2018seed and soil\u2019 hypothesis revisited. Nat Rev Cancer 3:453\u2013458","journal-title":"Nat Rev Cancer"},{"key":"362_CR10","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1172\/JCI118947","volume":"98","author":"TA Guise","year":"1996","unstructured":"Guise TA et al (1996) Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis. J Clin Invest 98:1544\u20131549","journal-title":"J Clin Invest"},{"key":"362_CR11","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1126\/science.3616618","volume":"237","author":"LJ Suva","year":"1987","unstructured":"Suva LJ et al (1987) A parathyroid hormone-related protein implicated in malignant hypercalcemia: cloning and expression. Science 237:893\u2013896","journal-title":"Science"},{"key":"362_CR12","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1681\/ASN.2007090981","volume":"19","author":"GR Mundy","year":"2008","unstructured":"Mundy GR, Edwards JR (2008) PTH-related peptide (PTHrP) in hypercalcemia. J Am Soc Nephrol 19:672\u2013675","journal-title":"J Am Soc Nephrol"},{"key":"362_CR13","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","volume":"100","author":"D Hanahan","year":"2000","unstructured":"Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100:57\u201370","journal-title":"Cell"},{"key":"362_CR14","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646\u2013674","journal-title":"Cell"},{"key":"362_CR15","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.jbo.2013.01.002","volume":"2","author":"RE Coleman","year":"2013","unstructured":"Coleman RE et al (2013) Possible survival benefits from zoledronic acid treatment in patients with bone metastases from solid tumours and poor prognostic features-An exploratory analysis of placebo-controlled trials. J Bone Oncol 2:70\u201376","journal-title":"J Bone Oncol"},{"key":"362_CR16","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/nrc865","volume":"2","author":"AF Chambers","year":"2002","unstructured":"Chambers AF, Groom AC, MacDonald IC (2002) Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2:563\u2013572","journal-title":"Nat Rev Cancer"},{"key":"362_CR17","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/nrclinonc.2009.44","volume":"6","author":"K Pantel","year":"2009","unstructured":"Pantel K, Alix-Panabieres C, Riethdorf S (2009) Cancer micrometastases. Nat Rev Clin Oncol 6:339\u2013351","journal-title":"Nat Rev Clin Oncol"},{"key":"362_CR18","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/nrc1370","volume":"4","author":"K Pantel","year":"2004","unstructured":"Pantel K, Brakenhoff RH (2004) Dissecting the metastatic cascade. Nat Rev Cancer 4:448\u2013456","journal-title":"Nat Rev Cancer"},{"key":"362_CR19","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/nrclinonc.2009.23","volume":"6","author":"K Pantel","year":"2009","unstructured":"Pantel K, Riethdorf S (2009) Pathology: are circulating tumor cells predictive of overall survival? Nat Rev Clin Oncol 6:190\u2013191","journal-title":"Nat Rev Clin Oncol"},{"key":"362_CR20","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/nrc2627","volume":"9","author":"CA Klein","year":"2009","unstructured":"Klein CA (2009) Parallel progression of primary tumours and metastases. Nat Rev Cancer 9:302\u2013312","journal-title":"Nat Rev Cancer"},{"key":"362_CR21","doi-asserted-by":"publisher","first-page":"340ra373","DOI":"10.1126\/scitranslmed.aad4059","volume":"8","author":"TT Price","year":"2016","unstructured":"Price TT et al (2016) Dormant breast cancer micrometastases reside in specific bone marrow niches that regulate their transit to and from bone. Sci Transl Med 8:340ra373","journal-title":"Sci Transl Med"},{"key":"362_CR22","doi-asserted-by":"publisher","first-page":"6389","DOI":"10.1158\/1078-0432.CCR-13-0838","volume":"19","author":"XH Zhang","year":"2013","unstructured":"Zhang XH, Giuliano M, Trivedi MV, Schiff R, Osborne CK (2013) Metastasis dormancy in estrogen receptor-positive breast cancer. Clin Cancer Res 19:6389\u20136397","journal-title":"Clin Cancer Res"},{"key":"362_CR23","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/nrc.2016.44","volume":"16","author":"PI Croucher","year":"2016","unstructured":"Croucher PI, McDonald MM, Martin TJ (2016) Bone metastasis: the importance of the neighbourhood. Nat Rev Cancer 16:373\u2013386","journal-title":"Nat Rev Cancer"},{"key":"362_CR24","doi-asserted-by":"publisher","first-page":"693","DOI":"10.2174\/1389450116666150309121346","volume":"17","author":"MJ Alvarez-Cubero","year":"2016","unstructured":"Alvarez-Cubero MJ et al (2016) Dormant circulating tumor cells in prostate cancer: therapeutic, clinical and biological implications. Curr Drug Targets 17:693\u2013701","journal-title":"Curr Drug Targets"},{"key":"362_CR25","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1002\/1878-0261.12022","volume":"11","author":"A Dasgupta","year":"2017","unstructured":"Dasgupta A, Lim AR, Ghajar CM (2017) Circulating and disseminated tumor cells: harbingers or initiators of metastasis? Mol Oncol 11:40\u201361","journal-title":"Mol Oncol"},{"key":"362_CR26","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.ccr.2006.07.019","volume":"10","author":"RR Gomis","year":"2006","unstructured":"Gomis RR, Alarcon C, Nadal C, Van Poznak C, Massague J (2006) C\/EBPbeta at the core of the TGFbeta cytostatic response and its evasion in metastatic breast cancer cells. Cancer Cell 10:203\u2013214","journal-title":"Cancer Cell"},{"key":"362_CR27","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1126\/science.aaa6592","volume":"347","author":"C Tomasetti","year":"2015","unstructured":"Tomasetti C, Vogelstein B (2015) Cancer risk: role of environment-response. Science 347:729\u2013731","journal-title":"Science"},{"key":"362_CR28","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s00109-013-1021-5","volume":"91","author":"HA Smith","year":"2013","unstructured":"Smith HA, Kang Y (2013) The metastasis-promoting roles of tumor-associated immune cells. J Mol Med (Berl) 91:411\u2013429","journal-title":"J Mol Med (Berl)"},{"key":"362_CR29","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/ncb2767","volume":"15","author":"CM Ghajar","year":"2013","unstructured":"Ghajar CM et al (2013) The perivascular niche regulates breast tumour dormancy. Nat Cell Biol 15:807\u2013817","journal-title":"Nat Cell Biol"},{"key":"362_CR30","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1001\/jama.2011.1034","volume":"306","author":"AE Giuliano","year":"2011","unstructured":"Giuliano AE et al (2011) Association of occult metastases in sentinel lymph nodes and bone marrow with survival among women with early-stage invasive breast cancer. JAMA 306:385\u2013393","journal-title":"JAMA"},{"key":"362_CR31","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/SLA.0b013e3181f08f32","volume":"252","author":"AE Giuliano","year":"2010","unstructured":"Giuliano AE et al (2010) Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial. Ann Surg 252:426\u2013432 discussion 432\u2013423","journal-title":"Ann Surg"},{"key":"362_CR32","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1002\/jso.21693","volume":"103","author":"CT Viehl","year":"2011","unstructured":"Viehl CT et al (2011) Prognostic impact and therapeutic implications of sentinel lymph node micro-metastases in early-stage breast cancer patients. J Surg Oncol 103:531\u2013533","journal-title":"J Surg Oncol"},{"key":"362_CR33","first-page":"1786","volume":"61","author":"T Karpanen","year":"2001","unstructured":"Karpanen T et al (2001) Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth. Cancer Res 61:1786\u20131790","journal-title":"Cancer Res"},{"key":"362_CR34","doi-asserted-by":"publisher","first-page":"4451","DOI":"10.1210\/endo.140.10.7037","volume":"140","author":"R Thomas","year":"1999","unstructured":"Thomas R et al (1999) Breast cancer cells interact with osteoblasts to support osteoclast formation. Endocrinology 140:4451\u20134458","journal-title":"Endocrinology"},{"key":"362_CR35","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1038\/ncb3408","volume":"18","author":"RW Johnson","year":"2016","unstructured":"Johnson RW et al (2016) Induction of LIFR confers a dormancy phenotype in breast cancer cells disseminated to the bone marrow. Nat Cell Biol 18:1078\u20131089","journal-title":"Nat Cell Biol"},{"key":"362_CR36","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.ccell.2014.11.017","volume":"27","author":"H Wang","year":"2015","unstructured":"Wang H et al (2015) The osteogenic niche promotes early-stage bone colonization of disseminated breast cancer cells. Cancer Cell 27:193\u2013210","journal-title":"Cancer Cell"},{"key":"362_CR37","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1016\/S0959-8049(03)00382-4","volume":"39","author":"FJ Hoar","year":"2003","unstructured":"Hoar FJ, Chaudhri S, Wadley MS, Stonelake PS (2003) Co-expression of vascular endothelial growth factor C (VEGF-C) and c-erbB2 in human breast carcinoma. Eur J Cancer 39:1698\u20131703","journal-title":"Eur J Cancer"},{"key":"362_CR38","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.prp.2008.01.015","volume":"204","author":"HR Park","year":"2008","unstructured":"Park HR, Min K, Kim HS, Jung WW, Park YK (2008) Expression of vascular endothelial growth factor-C and its receptor in osteosarcomas. Pathol Res Pract 204:575\u2013582","journal-title":"Pathol Res Pract"},{"key":"362_CR39","doi-asserted-by":"publisher","first-page":"38566","DOI":"10.18632\/oncotarget.9570","volume":"7","author":"HE Tzeng","year":"2016","unstructured":"Tzeng HE, Chang AC, Tsai CH, Wang SW, Tang CH (2016) Basic fibroblast growth factor promotes VEGF-C-dependent lymphangiogenesis via inhibition of miR-381 in human chondrosarcoma cells. Oncotarget 7:38566\u201338578","journal-title":"Oncotarget"},{"key":"362_CR40","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1042\/CS20160117","volume":"130","author":"CY Huang","year":"2016","unstructured":"Huang CY et al (2016) Adiponectin promotes VEGF-C-dependent lymphangiogenesis by inhibiting miR-27b through a CaMKII\/AMPK\/p38 signaling pathway in human chondrosarcoma cells. Clin Sci (Lond) 130:1523\u20131533","journal-title":"Clin Sci (Lond)"},{"key":"362_CR41","doi-asserted-by":"publisher","first-page":"28647","DOI":"10.1038\/srep28647","volume":"6","author":"WH Yang","year":"2016","unstructured":"Yang WH et al (2016) Leptin promotes VEGF-C production and induces lymphangiogenesis by suppressing miR-27b in human chondrosarcoma cells. Sci Rep 6:28647","journal-title":"Sci Rep"},{"key":"362_CR42","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1172\/JCI0217124","volume":"110","author":"TJ Martin","year":"2002","unstructured":"Martin TJ (2002) Manipulating the environment of cancer cells in bone: a novel therapeutic approach. J Clin Invest 110:1399\u20131401","journal-title":"J Clin Invest"},{"key":"362_CR43","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s10911-004-1404-x","volume":"9","author":"MJ Paszek","year":"2004","unstructured":"Paszek MJ, Weaver VM (2004) The tension mounts: mechanics meets morphogenesis and malignancy. J Mammary Gland Biol Neoplasia 9:325\u2013342","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"362_CR44","doi-asserted-by":"publisher","first-page":"84","DOI":"10.3390\/cancers9070084","volume":"9","author":"KA Kwakwa","year":"2017","unstructured":"Kwakwa KA, Sterling JA (2017) Integrin alphavbeta3 signaling in tumor-induced bone disease. Cancers (Basel) 9:84","journal-title":"Cancers (Basel)"},{"key":"362_CR45","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s11914-017-0385-9","volume":"15","author":"KA Kwakwa","year":"2017","unstructured":"Kwakwa KA, Vanderburgh JP, Guelcher SA, Sterling JA (2017) Engineering 3D models of tumors and bone to understand tumor-induced bone disease and improve treatments. Curr Osteoporos Rep 15:247\u2013254","journal-title":"Curr Osteoporos Rep"},{"key":"362_CR46","doi-asserted-by":"publisher","first-page":"e15451","DOI":"10.1371\/journal.pone.0015451","volume":"5","author":"NS Ruppender","year":"2010","unstructured":"Ruppender NS et al (2010) Matrix rigidity induces osteolytic gene expression of metastatic breast cancer cells. PLoS ONE 5:e15451","journal-title":"PLoS ONE"},{"key":"362_CR47","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1007\/s10585-014-9682-1","volume":"31","author":"RW Johnson","year":"2014","unstructured":"Johnson RW et al (2014) Wnt signaling induces gene expression of factors associated with bone destruction in lung and breast cancer. Clin Exp Metastasis 31:945\u2013959","journal-title":"Clin Exp Metastasis"},{"key":"362_CR48","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.biomaterials.2015.06.026","volume":"64","author":"JM Page","year":"2015","unstructured":"Page JM et al (2015) Matrix rigidity regulates the transition of tumor cells to a bone-destructive phenotype through integrin beta3 and TGF-beta receptor type II. Biomaterials 64:33\u201344","journal-title":"Biomaterials"},{"key":"362_CR49","doi-asserted-by":"publisher","first-page":"9669","DOI":"10.18632\/oncotarget.3430","volume":"6","author":"SR Amend","year":"2015","unstructured":"Amend SR, Pienta KJ (2015) Ecology meets cancer biology: the cancer swamp promotes the lethal cancer phenotype. Oncotarget 6:9669\u20139678","journal-title":"Oncotarget"},{"key":"362_CR50","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s11914-017-0378-8","volume":"15","author":"RW Johnson","year":"2017","unstructured":"Johnson RW, Sowder ME, Giaccia AJ (2017) Hypoxia and bone metastatic disease. Curr Osteoporos Rep 15:231\u2013238","journal-title":"Curr Osteoporos Rep"},{"key":"362_CR51","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/nature13034","volume":"508","author":"JA Spencer","year":"2014","unstructured":"Spencer JA et al (2014) Direct measurement of local oxygen concentration in the bone marrow of live animals. Nature 508:269\u2013273","journal-title":"Nature"},{"key":"362_CR52","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/S0006-3495(01)75733-5","volume":"81","author":"DC Chow","year":"2001","unstructured":"Chow DC, Wenning LA, Miller WM, Papoutsakis ET (2001) Modeling pO(2) distributions in the bone marrow hematopoietic compartment. II. Modified Kroghian models. Biophys J 81:685\u2013696","journal-title":"Biophys J"},{"key":"362_CR53","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1182\/blood.V99.1.394","volume":"99","author":"JS Harrison","year":"2002","unstructured":"Harrison JS, Rameshwar P, Chang V, Bandari P (2002) Oxygen saturation in the bone marrow of healthy volunteers. Blood 99:394","journal-title":"Blood"},{"key":"362_CR54","first-page":"5571","volume":"62","author":"MS Bendre","year":"2002","unstructured":"Bendre MS et al (2002) Expression of interleukin 8 and not parathyroid hormone-related protein by human breast cancer cells correlates with bone metastasis in vivo. Cancer Res 62:5571\u20135579","journal-title":"Cancer Res"},{"key":"362_CR55","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1038\/sj.bjc.6601585","volume":"90","author":"SC Chou","year":"2004","unstructured":"Chou SC, Azuma Y, Varia MA, Raleigh JA (2004) Evidence that involucrin, a marker for differentiation, is oxygen regulated in human squamous cell carcinomas. Br J Cancer 90:728\u2013735","journal-title":"Br J Cancer"},{"key":"362_CR56","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1002\/ijc.2910610422","volume":"61","author":"MW Gross","year":"1995","unstructured":"Gross MW, Karbach U, Groebe K, Franko AJ, Mueller-Klieser W (1995) Calibration of misonidazole labeling by simultaneous measurement of oxygen tension and labeling density in multicellular spheroids. Int J Cancer 61:567\u2013573","journal-title":"Int J Cancer"},{"key":"362_CR57","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.cmet.2015.08.007","volume":"22","author":"F Dupuy","year":"2015","unstructured":"Dupuy F et al (2015) PDK1-dependent metabolic reprogramming dictates metastatic potential in breast cancer. Cell Metab 22:577\u2013589","journal-title":"Cell Metab"},{"key":"362_CR58","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/nrc867","volume":"2","author":"GR Mundy","year":"2002","unstructured":"Mundy GR (2002) Metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev Cancer 2:584\u2013593","journal-title":"Nat Rev Cancer"},{"key":"362_CR59","doi-asserted-by":"publisher","first-page":"8983","DOI":"10.1038\/ncomms9983","volume":"6","author":"MA Lawson","year":"2015","unstructured":"Lawson MA et al (2015) Osteoclasts control reactivation of dormant myeloma cells by remodelling the endosteal niche. Nat Commun 6:8983","journal-title":"Nat Commun"},{"key":"362_CR60","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1172\/JCI39104","volume":"119","author":"R Kalluri","year":"2009","unstructured":"Kalluri R, Weinberg RA (2009) The basics of epithelial-mesenchymal transition. J Clin Invest 119:1420\u20131428","journal-title":"J Clin Invest"},{"key":"362_CR61","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1158\/2159-8290.CD-14-0621","volume":"5","author":"S Junankar","year":"2015","unstructured":"Junankar S et al (2015) Real-time intravital imaging establishes tumor-associated macrophages as the extraskeletal target of bisphosphonate action in cancer. Cancer Discov 5:35\u201342","journal-title":"Cancer Discov"},{"key":"362_CR62","doi-asserted-by":"publisher","first-page":"108451","DOI":"10.1155\/2015\/108451","volume":"2015","author":"G Mori","year":"2015","unstructured":"Mori G, D\u2019Amelio P, Faccio R, Brunetti G (2015) Bone-immune cell crosstalk: bone diseases. J Immunol Res 2015:108451","journal-title":"J Immunol Res"},{"key":"362_CR63","doi-asserted-by":"publisher","first-page":"315024","DOI":"10.1155\/2013\/315024","volume":"2013","author":"I Roato","year":"2013","unstructured":"Roato I (2013) Interaction among cells of bone, immune system, and solid tumors leads to bone metastases. Clin Dev Immunol 2013:315024","journal-title":"Clin Dev Immunol"},{"key":"362_CR64","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1172\/JCI31537","volume":"117","author":"WW Lin","year":"2007","unstructured":"Lin WW, Karin M (2007) A cytokine-mediated link between innate immunity, inflammation, and cancer. J Clin Invest 117:1175\u20131183","journal-title":"J Clin Invest"},{"key":"362_CR65","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s10549-006-9438-y","volume":"105","author":"YS Lau","year":"2007","unstructured":"Lau YS et al (2007) RANKL-dependent and RANKL-independent mechanisms of macrophage-osteoclast differentiation in breast cancer. Breast Cancer Res Treat 105:7\u201316","journal-title":"Breast Cancer Res Treat"},{"key":"362_CR66","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/S0140-6736(00)04046-0","volume":"357","author":"F Balkwill","year":"2001","unstructured":"Balkwill F, Mantovani A (2001) Inflammation and cancer: back to Virchow? Lancet 357:539\u2013545","journal-title":"Lancet"},{"key":"362_CR67","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1097\/01.bor.0000231909.35043.da","volume":"18","author":"PG Fournier","year":"2006","unstructured":"Fournier PG, Chirgwin JM, Guise TA (2006) New insights into the role of T cells in the vicious cycle of bone metastases. Curr Opin Rheumatol 18:396\u2013404","journal-title":"Curr Opin Rheumatol"},{"key":"362_CR68","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1002\/jbmr.3142","volume":"32","author":"A Kamalakar","year":"2017","unstructured":"Kamalakar A et al (2017) PTHrP(12-48) modulates the bone marrow microenvironment and suppresses human osteoclast differentiation and lifespan. J Bone Miner Res 32:1421\u20131431","journal-title":"J Bone Miner Res"},{"key":"362_CR69","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.jbo.2016.02.007","volume":"5","author":"R Leblanc","year":"2016","unstructured":"Leblanc R, Peyruchaud O (2016) The role of platelets and megakaryocytes in bone metastasis. J Bone Oncol 5:109\u2013111","journal-title":"J Bone Oncol"},{"key":"362_CR70","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1210\/er.2012-1026","volume":"34","author":"SL Dallas","year":"2013","unstructured":"Dallas SL, Prideaux M, Bonewald LF (2013) The osteocyte: an endocrine cell\u2026 and more. Endocr Rev 34:658\u2013690","journal-title":"Endocr Rev"},{"key":"362_CR71","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1002\/ar.a.20032","volume":"278","author":"C Palumbo","year":"2004","unstructured":"Palumbo C, Ferretti M, Marotti G (2004) Osteocyte dendrogenesis in static and dynamic bone formation: an ultrastructural study. Anat Rec A 278:474\u2013480","journal-title":"Anat Rec A"},{"key":"362_CR72","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1038\/nm.2452","volume":"17","author":"T Nakashima","year":"2011","unstructured":"Nakashima T et al (2011) Evidence for osteocyte regulation of bone homeostasis through RANKL expression. Nat Med 17:1231\u20131234","journal-title":"Nat Med"},{"key":"362_CR73","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1038\/nm.2448","volume":"17","author":"J Xiong","year":"2011","unstructured":"Xiong J et al (2011) Matrix-embedded cells control osteoclast formation. Nat Med 17:1235\u20131241","journal-title":"Nat Med"},{"key":"362_CR74","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1038\/leu.2011.381","volume":"26","author":"N Giuliani","year":"2012","unstructured":"Giuliani N et al (2012) Increased osteocyte death in multiple myeloma patients: role in myeloma-induced osteoclast formation. Leukemia 26:1391\u20131401","journal-title":"Leukemia"},{"key":"362_CR75","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1038\/nrendo.2010.227","volume":"7","author":"LJ Suva","year":"2011","unstructured":"Suva LJ, Washam C, Nicholas RW, Griffin RJ (2011) Bone metastasis: mechanisms and therapeutic opportunities. Nat Rev Endocrinol 7:208\u2013218","journal-title":"Nat Rev Endocrinol"},{"key":"362_CR76","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1517\/14728222.2012.697154","volume":"16","author":"M Gkotzamanidou","year":"2012","unstructured":"Gkotzamanidou M et al (2012) Sclerostin: a possible target for the management of cancer-induced bone disease. Expert Opin Ther Targets 16:761\u2013769","journal-title":"Expert Opin Ther Targets"},{"key":"362_CR77","doi-asserted-by":"publisher","first-page":"R106","DOI":"10.1186\/bcr3048","volume":"13","author":"D Mendoza-Villanueva","year":"2011","unstructured":"Mendoza-Villanueva D, Zeef L, Shore P (2011) Metastatic breast cancer cells inhibit osteoblast differentiation through the Runx2\/CBFbeta-dependent expression of the Wnt antagonist, sclerostin. Breast Cancer Res 13:R106","journal-title":"Breast Cancer Res"},{"key":"362_CR78","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1001\/jamaoncol.2015.5768","volume":"2","author":"C Wilson","year":"2016","unstructured":"Wilson C, Coleman R (2016) Adjuvant bone-targeted therapies for postmenopausal breast cancer. JAMA Oncol 2:423\u2013424","journal-title":"JAMA Oncol"},{"key":"362_CR79","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1016\/S0140-6736(15)60908-4","volume":"386","author":"Early Breast Cancer Trialists\u2019 Collaborative Group","year":"2015","unstructured":"Early Breast Cancer Trialists\u2019 Collaborative Group (2015) Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials. Lancet 386:1353\u20131361","journal-title":"Lancet"},{"key":"362_CR80","doi-asserted-by":"publisher","first-page":"79032","DOI":"10.18632\/oncotarget.12593","volume":"7","author":"H Taipaleenmaki","year":"2016","unstructured":"Taipaleenmaki H et al (2016) Antagonizing miR-218-5p attenuates Wnt signaling and reduces metastatic bone disease of triple negative breast cancer cells. Oncotarget 7:79032\u201379046","journal-title":"Oncotarget"},{"key":"362_CR81","doi-asserted-by":"publisher","first-page":"42084","DOI":"10.1074\/jbc.M112.377515","volume":"287","author":"MQ Hassan","year":"2012","unstructured":"Hassan MQ et al (2012) miR-218 directs a Wnt signaling circuit to promote differentiation of osteoblasts and osteomimicry of metastatic cancer cells. J Biol Chem 287:42084\u201342092","journal-title":"J Biol Chem"},{"key":"362_CR82","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1172\/JCI3523","volume":"103","author":"JJ Yin","year":"1999","unstructured":"Yin JJ et al (1999) TGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development. J Clin Invest 103:197\u2013206","journal-title":"J Clin Invest"},{"key":"362_CR83","doi-asserted-by":"publisher","first-page":"e27090","DOI":"10.1371\/journal.pone.0027090","volume":"6","author":"S Biswas","year":"2011","unstructured":"Biswas S et al (2011) Anti-transforming growth factor ss antibody treatment rescues bone loss and prevents breast cancer metastasis to bone. PLoS ONE 6:e27090","journal-title":"PLoS ONE"},{"key":"362_CR84","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1158\/0008-5472.CAN-10-2993","volume":"71","author":"RW Johnson","year":"2011","unstructured":"Johnson RW et al (2011) TGF-beta promotion of Gli2-induced expression of parathyroid hormone-related protein, an important osteolytic factor in bone metastasis, is independent of canonical Hedgehog signaling. Cancer Res 71:822\u2013831","journal-title":"Cancer Res"},{"key":"362_CR85","doi-asserted-by":"publisher","first-page":"7548","DOI":"10.1158\/0008-5472.CAN-06-0452","volume":"66","author":"JA Sterling","year":"2006","unstructured":"Sterling JA et al (2006) The hedgehog signaling molecule Gli2 induces parathyroid hormone-related peptide expression and osteolysis in metastatic human breast cancer cells. Cancer Res 66:7548\u20137553","journal-title":"Cancer Res"},{"key":"362_CR86","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1158\/0008-5472.CAN-11-2681","volume":"72","author":"E Heller","year":"2012","unstructured":"Heller E et al (2012) Hedgehog signaling inhibition blocks growth of resistant tumors through effects on tumor microenvironment. Cancer Res 72:897\u2013907","journal-title":"Cancer Res"},{"key":"362_CR87","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/35077219","volume":"411","author":"J Taipale","year":"2001","unstructured":"Taipale J, Beachy PA (2001) The Hedgehog and Wnt signalling pathways in cancer. Nature 411:349\u2013354","journal-title":"Nature"},{"key":"362_CR88","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1158\/0008-5472.CAN-10-2651","volume":"71","author":"KS Mohammad","year":"2011","unstructured":"Mohammad KS et al (2011) TGF-beta-RI kinase inhibitor SD-208 reduces the development and progression of melanoma bone metastases. Cancer Res 71:175\u2013184","journal-title":"Cancer Res"},{"key":"362_CR89","doi-asserted-by":"publisher","first-page":"76062","DOI":"10.18632\/oncotarget.12584","volume":"7","author":"SA Cannonier","year":"2016","unstructured":"Cannonier SA, Gonzales CB, Ely K, Guelcher SA, Sterling JA (2016) Hedgehog and TGFbeta signaling converge on Gli2 to control bony invasion and bone destruction in oral squamous cell carcinoma. Oncotarget 7:76062\u201376075","journal-title":"Oncotarget"},{"key":"362_CR90","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.pharmthera.2015.02.002","volume":"150","author":"RW Johnson","year":"2015","unstructured":"Johnson RW, Schipani E, Giaccia AJ (2015) HIF targets in bone remodeling and metastatic disease. Pharmacol Ther 150:169\u2013177","journal-title":"Pharmacol Ther"},{"key":"362_CR91","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/S8756-3282(03)00086-3","volume":"33","author":"MS Bendre","year":"2003","unstructured":"Bendre MS et al (2003) Interleukin-8 stimulation of osteoclastogenesis and bone resorption is a mechanism for the increased osteolysis of metastatic bone disease. Bone 33:28\u201337","journal-title":"Bone"},{"key":"362_CR92","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1007\/s10585-014-9680-3","volume":"31","author":"Y Zheng","year":"2014","unstructured":"Zheng Y et al (2014) Targeting IL-6 and RANKL signaling inhibits prostate cancer growth in bone. Clin Exp Metastasis 31:921\u2013933","journal-title":"Clin Exp Metastasis"},{"key":"362_CR93","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.celrep.2015.12.016","volume":"14","author":"X Luo","year":"2016","unstructured":"Luo X et al (2016) Stromal-initiated changes in the bone promote metastatic niche development. Cell Rep 14:82\u201392","journal-title":"Cell Rep"},{"key":"362_CR94","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1038\/nm1013-1193","volume":"19","author":"SC Williams","year":"2013","unstructured":"Williams SC (2013) First IL-6-blocking drug nears approval for rare blood disorder. Nat Med 19:1193","journal-title":"Nat Med"},{"key":"362_CR95","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.3390\/ijms18071414","volume":"18","author":"T Eckschlager","year":"2017","unstructured":"Eckschlager T, Plch J, Stiborova M, Hrabeta J (2017) Histone deacetylase inhibitors as anticancer drugs. Int J Mol Sci 18:1414","journal-title":"Int J Mol Sci"},{"key":"362_CR96","doi-asserted-by":"publisher","first-page":"3210","DOI":"10.1158\/1535-7163.MCT-10-0572","volume":"9","author":"J Pratap","year":"2010","unstructured":"Pratap J et al (2010) The histone deacetylase inhibitor, vorinostat, reduces tumor growth at the metastatic bone site and associated osteolysis, but promotes normal bone loss. Mol Cancer Ther 9:3210\u20133220","journal-title":"Mol Cancer Ther"},{"key":"362_CR97","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s10585-013-9625-2","volume":"31","author":"SR Larson","year":"2014","unstructured":"Larson SR et al (2014) Prostate cancer derived prostatic acid phosphatase promotes an osteoblastic response in the bone microenvironment. Clin Exp Metastasis 31:247\u2013256","journal-title":"Clin Exp Metastasis"},{"key":"362_CR98","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1002\/(SICI)1097-0142(19971015)80:8+<1588::AID-CNCR9>3.0.CO;2-G","volume":"80","author":"RE Coleman","year":"1997","unstructured":"Coleman RE (1997) Skeletal complications of malignancy. Cancer 80:1588\u20131594","journal-title":"Cancer"},{"key":"362_CR99","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/nrendo.2011.80","volume":"7","author":"LJ Suva","year":"2011","unstructured":"Suva LJ, Brander BE, Makhoul I (2011) Update on bone-modifying agents in metastatic breast cancer. Nat Rev Endocrinol 7:380\u2013381","journal-title":"Nat Rev Endocrinol"},{"key":"362_CR100","doi-asserted-by":"publisher","first-page":"5778","DOI":"10.1158\/0008-5472.CAN-05-0749","volume":"65","author":"T Kelly","year":"2005","unstructured":"Kelly T et al (2005) Expression of heparanase by primary breast tumors promotes bone resorption in the absence of detectable bone metastases. Cancer Res 65:5778\u20135784","journal-title":"Cancer Res"},{"key":"362_CR101","doi-asserted-by":"publisher","first-page":"e114530","DOI":"10.1371\/journal.pone.0114530","volume":"9","author":"BC Ozdemir","year":"2014","unstructured":"Ozdemir BC et al (2014) The molecular signature of the stroma response in prostate cancer-induced osteoblastic bone metastasis highlights expansion of hematopoietic and prostate epithelial stem cell niches. PLoS ONE 9:e114530","journal-title":"PLoS ONE"},{"key":"362_CR102","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1016\/j.cell.2009.11.025","volume":"139","author":"MY Kim","year":"2009","unstructured":"Kim MY et al (2009) Tumor self-seeding by circulating cancer cells. Cell 139:1315\u20131326","journal-title":"Cell"},{"key":"362_CR103","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.cell.2008.01.046","volume":"133","author":"D Padua","year":"2008","unstructured":"Padua D et al (2008) TGFbeta primes breast tumors for lung metastasis seeding through angiopoietin-like 4. Cell 133:66\u201377","journal-title":"Cell"},{"key":"362_CR104","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.celrep.2014.06.011","volume":"8","author":"M Vilalta","year":"2014","unstructured":"Vilalta M, Rafat M, Giaccia AJ, Graves EE (2014) Recruitment of circulating breast cancer cells is stimulated by radiotherapy. Cell Rep 8:402\u2013409","journal-title":"Cell Rep"},{"key":"362_CR105","first-page":"115","volume":"21","author":"S Manolagas","year":"2000","unstructured":"Manolagas S (2000) Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev 21:115\u2013137","journal-title":"Endocr Rev"},{"key":"362_CR106","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s10585-013-9622-5","volume":"31","author":"LM Martinez","year":"2014","unstructured":"Martinez LM et al (2014) Changes in the peripheral blood and bone marrow from untreated advanced breast cancer patients that are associated with the establishment of bone metastases. Clin Exp Metastasis 31:213\u2013232","journal-title":"Clin Exp Metastasis"},{"key":"362_CR107","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1002\/jor.22527","volume":"32","author":"KC Stine","year":"2014","unstructured":"Stine KC et al (2014) Cisplatin inhibits bone healing during distraction osteogenesis. J Orthop Res 32:464\u2013470","journal-title":"J Orthop Res"},{"key":"362_CR108","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1002\/jor.23192","volume":"34","author":"KC Stine","year":"2016","unstructured":"Stine KC et al (2016) Nutlin-3 treatment spares cisplatin-induced inhibition of bone healing while maintaining osteosarcoma toxicity. J Orthop Res 34:1716\u20131724","journal-title":"J Orthop Res"},{"key":"362_CR109","doi-asserted-by":"publisher","first-page":"e0138189","DOI":"10.1371\/journal.pone.0138189","volume":"10","author":"J Xiong","year":"2015","unstructured":"Xiong J et al (2015) Osteocytes, not osteoblasts or lining cells, are the main source of the RANKL required for osteoclast formation in remodeling bone. PLoS ONE 10:e0138189","journal-title":"PLoS ONE"},{"key":"362_CR110","first-page":"121","volume":"1866","author":"G Bultynck","year":"2016","unstructured":"Bultynck G (2016) The anti-metastatic micro-environment of the bone: importance of osteocyte Cx43 hemichannels. Biochim Biophys Acta 1866:121\u2013127","journal-title":"Biochim Biophys Acta"},{"key":"362_CR111","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/1878-0261.12024","volume":"11","author":"J Massague","year":"2017","unstructured":"Massague J, Batlle E, Gomis RR (2017) Understanding the molecular mechanisms driving metastasis. Mol Oncol 11:3\u20134","journal-title":"Mol Oncol"},{"key":"362_CR112","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1038\/nm.4336","volume":"23","author":"A Giustacchini","year":"2017","unstructured":"Giustacchini A et al (2017) Single-cell transcriptomics uncovers distinct molecular signatures of stem cells in chronic myeloid leukemia. Nat Med 23:692\u2013702","journal-title":"Nat Med"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00223-017-0362-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-017-0362-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-017-0362-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,7]],"date-time":"2022-08-07T05:45:28Z","timestamp":1659851128000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00223-017-0362-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,14]]},"references-count":112,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["362"],"URL":"https:\/\/doi.org\/10.1007\/s00223-017-0362-4","relation":{},"ISSN":["0171-967X","1432-0827"],"issn-type":[{"value":"0171-967X","type":"print"},{"value":"1432-0827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,14]]},"assertion":[{"value":"28 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}